Proliferative role of TRAF4 in breast cancer by upregulating PRMT5 nuclear expression
- PMID: 25704480
- DOI: 10.1007/s13277-015-3262-0
Proliferative role of TRAF4 in breast cancer by upregulating PRMT5 nuclear expression
Abstract
In this study, we examined protein arginine methyltransferase 5 (PRMT5) and tumor necrosis factor receptor-associated 4 (TRAF4) expression in breast cancer to find the interaction mechanism between the two. We examined TRAF4 and PRMT5 expression by immunohistochemistry and found that their expression is positively correlated in breast cancer. Besides, PRMT5 expression was significantly associated with histological type and tumor size (p < 0.05). PRMT5 nuclear expression was significantly associated with HER2 expression (p < 0.05). PRMT5 and TRAF4 were both overexpressed in breast cancer tissues and cells, and we found that PRMT5 binds to the zinc finger structures in TRAF4 by coimmunoprecipitation and Western blotting. We also tested the potential regulatory effect between TRAF4 and PRMT5. TRAF4 upregulated PRMT5 expression, which occurred predominantly in the nucleus, on which TRAF4 promotion of cell proliferation in breast cancer is mainly dependent. PRMT5 may play an important role in activation of the NF-κB signaling pathway.
Similar articles
-
Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.Biochem Biophys Res Commun. 2018 Jun 7;500(3):810-816. doi: 10.1016/j.bbrc.2018.04.164. Epub 2018 Apr 24. Biochem Biophys Res Commun. 2018. PMID: 29684350
-
TRAF2 regulates the cytoplasmic/nuclear distribution of TRAF4 and its biological function in breast cancer cells.Biochem Biophys Res Commun. 2013 Jun 28;436(2):344-8. doi: 10.1016/j.bbrc.2013.05.107. Epub 2013 Jun 4. Biochem Biophys Res Commun. 2013. PMID: 23743189
-
Expression, correlation, and prognostic value of TRAF2 and TRAF4 expression in malignant plural effusion cells in human breast cancer.Diagn Cytopathol. 2015 Nov;43(11):897-903. doi: 10.1002/dc.23330. Epub 2015 Aug 31. Diagn Cytopathol. 2015. PMID: 26331901
-
TRAF4 mediates activation of TGF-β signaling and is a biomarker for oncogenesis in breast cancer.Sci China Life Sci. 2014 Dec;57(12):1172-6. doi: 10.1007/s11427-014-4727-x. Epub 2014 Sep 24. Sci China Life Sci. 2014. PMID: 25249198 Review.
-
Clinicopathological and Prognostic Significance of PRMT5 in Cancers: A System Review and Meta-Analysis.Cancer Control. 2021 Jan-Dec;28:10732748211050583. doi: 10.1177/10732748211050583. Cancer Control. 2021. PMID: 34758643 Free PMC article.
Cited by
-
PRMT5-regulated splicing of DNA repair genes drives chemoresistance in breast cancer stem cells.Oncogene. 2025 Apr;44(13):862-876. doi: 10.1038/s41388-024-03264-1. Epub 2024 Dec 18. Oncogene. 2025. PMID: 39695328 Free PMC article.
-
PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression.Cell Rep. 2017 Dec 19;21(12):3498-3513. doi: 10.1016/j.celrep.2017.11.096. Cell Rep. 2017. PMID: 29262329 Free PMC article.
-
TRAF Family Member 4 Promotes Cardiac Hypertrophy Through the Activation of the AKT Pathway.J Am Heart Assoc. 2023 Sep 5;12(17):e028185. doi: 10.1161/JAHA.122.028185. Epub 2023 Aug 29. J Am Heart Assoc. 2023. PMID: 37642020 Free PMC article.
-
Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors in Oncology Clinical Trials: A review.J Immunother Precis Oncol. 2022 Jun 22;5(3):58-67. doi: 10.36401/JIPO-22-1. eCollection 2022 Aug. J Immunother Precis Oncol. 2022. PMID: 36034581 Free PMC article. Review.
-
Protein arginine methyltransferases: promising targets for cancer therapy.Exp Mol Med. 2021 May;53(5):788-808. doi: 10.1038/s12276-021-00613-y. Epub 2021 May 18. Exp Mol Med. 2021. PMID: 34006904 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous